glp-1 and parkinson's disease A new Science Perspective highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes obesity, including cardiovascular and neurodegenerative disorders Neuroprotective Actions of Glucagon-Like Peptide-1

Do oral peptides need the same storage care

The lower limit of quantification was 3.6 pM (insulin) and 1.8 pM (leptin)

We encourage anyone considering medical weight loss to engage in open dialogue with their healthcare team

MicroRejuve is a microneedling treatment with Hyaluronic Acid Filler and Botox which offers no-downtime smoothing of fine lines and skin texture improvement

commercially available in creams and serums at concentrations of 1-3% Subcutaneous injection : Research doses typically 100-200 mcg administered locally Iontophoresis : Electrical delivery through skin has been studied for enhanced penetration Microneedling combination : Topical application combined with microneedling for deeper delivery The topical availability of GHK-Cu makes it significantly more accessible than BPC-157 for surface-level applications